Pfizer Inc. Website

Pfizer Inc.

NYSE-PFE

Basic

  • Market Cap

    $163.31B

  • EV

    $221.56B

  • Shares Out

    5,666.59M

  • Revenue

    $54.89B

  • Employees

    88,000

Margins

  • Gross

    59.41%

  • EBITDA

    17.53%

  • Operating

    5.65%

  • Pre-Tax

    -3.26%

  • Net

    -0.56%

  • FCF

    9.3%

Returns (5Yr Avg)

  • ROA

    9.42%

  • ROTA

    41.05%

  • ROE

    22.28%

  • ROCE

    13.26%

  • ROIC

    11.36%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $31.94

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $11.93B

  • Net Debt

    $57.97B

  • Debt/Equity

    0.76

  • EBIT/Interest

    1.16

Growth (CAGR)

  • Rev 3Yr

    6%

  • Rev 5Yr

    0.38%

  • Rev 10Yr

    0.83%

  • Dil EPS 3Yr

    -68.63%

  • Dil EPS 5Yr

    -50.39%

  • Dil EPS 10Yr

    -33.03%

  • Rev Fwd 2Yr

    3.54%

  • EBITDA Fwd 2Yr

    23.51%

  • EPS Fwd 2Yr

    21.74%

  • EPS LT Growth Est

    9.67%

Dividends

  • Yield

    —

  • Payout

    -3,236.31%

  • DPS

    $1.65

  • DPS Growth 3Yr

    2.55%

  • DPS Growth 5Yr

    3.64%

  • DPS Growth 10Yr

    5.35%

  • DPS Growth Fwd 2Yr

    1.53%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

40,905

41,651

81,288

100,330

58,496

54,889

Total Revenues % Chg.

0.2%

1.8%

95.2%

23.4%

-41.7%

-41.1%

Cost of Goods Sold, Total

7,847

8,385

30,686

34,097

23,989

22,278

Gross Profit

33,058

33,266

50,602

66,233

34,507

32,611

Selling General & Admin Expenses, Total

12,766

11,418

9,562

12,200

13,836

13,908

R&D Expenses

7,721

8,709

10,360

11,428

10,679

10,665

Amortization of Goodwill and Intangible Assets

4,429

3,348

3,700

3,609

4,733

4,938

Other Operating Expenses, Total

24,916

23,475

23,622

27,237

29,248

29,511

Operating Income

8,142

9,791

26,980

38,996

5,259

3,100

Interest Expense, Total

-1,573

-1,449

-1,291

-1,238

-2,209

-2,681

Interest And Investment Income

445

351

202

565

2,100

1,810

Net Interest Expenses

-1,128

-1,098

-1,089

-673

-109

-871

Income (Loss) On Equity Invest.

—

—

—

17

298

471

436

505

349

Currency Exchange Gains (Loss)

—

—

—

—

-1,153

164

164

Other Non Operating Income (Expenses)

1,365

1,639

1,904

2,619

1,275

1,175

EBT, Excl. Unusual Items

8,396

10,630

28,266

40,225

7,094

3,917

Restructuring Charges

-1,093

-837

-1,360

-2,025

-3,331

-3,392

Merger & Related Restructuring Charges

-2

-58

-92

-200

-668

-914

Gain (Loss) On Sale Of Investments

8,561

557

1,344

-1,273

1,590

2,216

Gain (Loss) On Sale Of Assets

32

-237

—

—

222

222

Asset Writedown

-2,792

-1,691

-86

-421

-3,024

-2,869

In Process R&D Expenses

—

—

—

—

—

—

-684

-3,469

-953

-194

-173

Legal Settlements

-292

-28

-182

-230

-474

-646

Other Unusual Items

-1,490

-616

-111

-394

-157

-152

EBT, Incl. Unusual Items

11,320

7,036

24,310

34,729

1,058

-1,791

Income Tax Expense

583

370

1,852

3,328

-1,115

-1,537

Earnings From Continuing Operations

10,737

6,666

22,458

31,401

2,173

-254

Earnings Of Discontinued Operations

5,318

2,529

-434

6

-15

-21

Minority Interest

-29

-36

-45

-35

-39

-34

Net Income

16,026

9,159

21,979

31,372

2,119

-309

Preferred Dividend and Other Adjustments

1

—

—

—

—

—

Net Income to Common Incl Extra Items

16,025

9,159

21,979

31,372

2,119

-309

Net Income to Common Excl. Extra Items

10,707

6,630

22,413

31,366

2,134

-288

Total Shares Outstanding

5,534

5,567

5,620

5,616

5,646

5,667

Weighted Avg. Shares Outstanding

5,569

5,555

5,601

5,608

5,643

5,648.8

Weighted Avg. Shares Outstanding Dil

5,675

5,632

5,708

5,733

5,709

5,648.8

EPS

2.9

1.6

3.9

5.6

0.4

-0.1

EPS Diluted

2.8

1.6

3.9

5.5

0.4

-0.1

EBITDA

13,857

14,455

32,084

44,024

11,517

9,621

Effective Tax Rate

5.2%

5.3%

7.6%

9.6%

-105.4%

85.8%